Breaking News
21 minutes ago
Simantini Singh Deo
Catalyst Pharmaceuticals secures the 11th spot on Forbes’ 2026 America’s Most Successful Small-Cap Companies list.
Simantini Singh Deo
Revolution Medicines’ zoldonrasib receives FDA Breakthrough designation for KRAS G12D-mutated advanced NSCLC.
Simantini Singh Deo
MUSC Health and Baxter form a strategic partnership to improve nursing efficiency, care quality, and connected healthcare delivery.
Vaibhavi M.
Ascendis shows durable growth, improved body proportionality, and favorable safety with TransCon CNP plus TransCon hGH in achondroplasia.
Vaibhavi M.